Search Results
Results found for "Josh Gross"
- Dr. Juan José Fung - Dr. GPCR Podcast
Juan Jose Fung, Principal Scientist, at GPCR Therapeutics.
- Dr. Ross Bathgate becomes Scientific co-founder of LASEREDD Therapeutics
I’m happy to share that I’m starting a new position as Scientific co-founder LASEREDD Therapeutics" Ross
- Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes
Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes: Impact of of 11 Class A GPCR crystallized in multiple activation states (giving rise to 37 self-docking and 68 cross Our results show that one specific subset of cross-docking simulations gave results of similar quality RMSD values for top-scored poses were 1.2 Å and 2.0 Å for self-docking and StateMatch/FunctionMatch cross-docking
- Crinetics Pharmaceuticals Announces Pricing Of Underwritten Common Stock Offering
The gross proceeds to Crinetics from the offering, before deducting the underwriting discounts and commissions
- Addex Raises $10 Million In Equity Financing
Company agreed to sell 3,752,202 shares in the form of 625,367 American Depositary Shares (“ADSs”) at a gross
- Addex raises $4.2 million in equity financing
investor, to sell 3,300,000 shares in the form of 550,000 American Depositary Shares (“ADSs”) at a gross
- Dr. GPCR Updates
It highlights its journey from one receptor to a cross-family toolkit. Hear from Drs.
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
The cross-talk between growth factor receptors and GPCRs is an intriguing area of study. consequences of specific phosphorylation events provide a deeper understanding of the molecular basis for cross-talk
- Diversification of PAR signaling through receptor crosstalk
physiological and pathological relevance of these interactions, since this additional level of molecular cross-talk
- Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology
We collaborate and cross-pollenate a lot.”
- Profiling Immune Cell and Platelet Transcriptomes
these receptors were also detected, highlighting the robustness of the assay and the potential for cross-validation
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Helen Su , et al. for their fantastic work on Germline mutations in a G protein identify signaling cross-talk research position GPCR Activation and Signaling Germline mutations in a G protein identify signaling cross-talk
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Heterodimerization when Expressed Heterologously in Saccharomyces cerevisiae The beta 2 adrenergic receptor cross-linked
- Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembra
They often form homo- and heterodimers with allosteric cross-talk between receptor entities, which contributes
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
Rafael Rivas-Santisteban , Ana Muñoz , Jaume Lillo , Iu Raïch , Ana Rodríguez-Pérez , Gemma Navarro , José
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
Once a ligand crosses into this intracellular space, it behaves differently, often much more favorably
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Heterodimerization when Expressed Heterologously in Saccharomyces cerevisiae The beta 2 adrenergic receptor cross-linked
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
operational details, such as misaligned data from diverse GPCR assay types or communication gaps in cross-functional
- 📰 GPCR Weekly News
GPCR Industry News Septerna Announces the Formation of a Cross-Functional Scientific and Drug Discovery
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
With rigor, transparency, and cross-disciplinary collaboration, they’re pushing GPCR science toward a
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
He also underscores the value of developing cross-functional skills — including communication, strategy
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
stable, are believed to influence the function and regulation of GPCRs—a process known as receptor cross-talk
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Early cross-screening can flag biased phenotypes long before animal studies.
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
This is especially useful in GPCRs, where structural similarity happens often and thus cross-reactivity
- 📰 GPCR Weekly News, November 6 to November 12, 2023
through binding to ADGRL1 and activating cAMP/PKA/CREB/BCL2 signaling pathway Deciphering specificity and cross-reactivity
- 📰 GPCR Weekly News, June 5 to 11, 2023
Ines Liebscher, Ross Cheloha and Silvio Gutkind.
- Chemokine receptor-targeted drug discovery: progress and challenges
Further difficulties arise from the existence of cross-reactivity with other GPCRs and differences in
- GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures
EC₅₀ and Emax uncouple affinity and efficacy, making cross-agonist comparison unreliable. Dr.
- 📰 GPCR Weekly News, May 27 to June 2, 2024
Canonical chemokine receptors as scavenging “decoys” Shivani Sachdev, Brendan Creemer, Thomas Gardella, and Ross
- 📰 GPCR Weekly News, February 12 to 18, 2024
Nayara Braga Emidio, Ross Cheloha, Laura M Wingler, et al. for their work on Nanobody-Mediated Dualsteric













